NASDAQ: NBP
Novabridge Biosciences Stock Ownership - Who owns Novabridge Biosciences?

Insider buying vs selling

Have Novabridge Biosciences insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mark Arnold HaglerPresident and Chief Commercial Officer2026-04-24230,000$2.51
$577.30kBuy

1 of 1

NBP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NBP insiders and whales buy or sell their stock.

NBP Shareholders

What type of owners hold Novabridge Biosciences stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Wei Fu11.49%30,499,699$73.20MInsider
Janus Henderson Group PLC3.18%8,436,641$20.25MInstitution
Hhlr Advisors Ltd2.25%5,980,568$14.35MInstitution
Morgan Stanley1.43%3,785,502$9.09MInstitution
Siren LLC1.13%3,000,000$7.20MInstitution
Point72 Asset Management LP0.87%2,298,501$5.52MInstitution
Ariose Capital Management Ltd0.51%1,363,515$3.27MInstitution
Candriam Sca0.43%1,132,563$2.72MInstitution
Woodline Partners LP0.40%1,050,000$2.52MInstitution
Adage Capital Partners GP LLC0.38%1,000,000$2.40MInstitution

1 of 3

NBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NBP12.51%12.12%Net BuyingNet Buying
FATE51.21%48.79%Net Selling
CLLS14.58%0.00%
CHRS34.23%14.29%Net Selling
ALEC64.04%35.96%Net SellingNet Selling

Novabridge Biosciences Stock Ownership FAQ

Who owns Novabridge Biosciences?

Novabridge Biosciences (NASDAQ: NBP) is owned by 12.51% institutional shareholders, 12.12% Novabridge Biosciences insiders, and 75.37% retail investors. Wei Fu is the largest individual Novabridge Biosciences shareholder, owning 30.50M shares representing 11.49% of the company. Wei Fu's Novabridge Biosciences shares are currently valued at $72.59M.

If you're new to stock investing, here's how to buy Novabridge Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.